1921
Volume 100, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Mass drug administration (MDA) with ivermectin must reach a high treatment coverage (90% of the eligible population) if onchocerciasis is to be eliminated. Questions have been raised as to whether reported treatment figures reaching such high coverage are reliable. Sample surveys are proposed as the method of choice for “validating” reported coverage figures. The purpose of this study was to compare the district-level MDA coverage reported by programs with contemporaneous surveys of randomly selected respondents living in those same districts. Over an 8-year period, 19,219 households were selected using multistage random sampling; 38,433 adult male and female heads of those households were asked about their recent ivermectin MDA treatment experience. District coverage reports were considered “accurate” if they fell within the 95% CIs determined by the corresponding district’s survey. Ninety-eight treatment rounds were evaluated over an 8-year period. Overall, the reported coverage of 96.5% (range: 68–100%) was significantly higher than the 92.5% surveyed coverage (range: 62.1–99.6%, 95% CI: 91.9–93.2%). However, only 20% of districts reported significantly higher coverage than surveys, 68% of district program reports were judged as accurate, and 12% of districts reported significantly lower coverage figures than their corresponding surveys. Eighty-eight percent of districts reported coverage ≥ 90% threshold for success, compared with 97% of surveys that included 90% in their 95% CIs. We conclude that when analyzed statistically at the district level, most surveys verified the reported coverage.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0680
2019-03-25
2020-09-26
Loading full text...

Full text loading...

/deliver/fulltext/14761645/100/5/tpmd180680.html?itemId=/content/journals/10.4269/ajtmh.18-0680&mimeType=html&fmt=ahah

References

  1. Amazigo UV, Obono M, Dadzie KY, Remme J, Jiya J, Ndyomugyenyi R, Roungou JB, Noma M, Seketeli A, 2002. Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 96 (Suppl 1): S75S92.
    [Google Scholar]
  2. Katabarwa MN, Habomugisha P, Richards FO Jr., 2002. Implementing community-directed treatment with ivermectin for the control of onchocerciasis in Uganda (1997–2000): an evaluation. Ann Trop Med Parasitol 96: 6173.
    [Google Scholar]
  3. Worrell C, Mathieu E, 2012. Drug coverage surveys for neglected tropical diseases: 10 years of field experience. Am J Trop Med Hyg 87: 216222.
    [Google Scholar]
  4. Amazigo UV, Brieger WR, Katabarwa M, Akogun O, Ntep M, Boatin B, N’Doyo J, Noma M, Seketeli A, 2002. The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 96 (Suppl 1): S41S58.
    [Google Scholar]
  5. Yaya G, Kobangué L, Kémata B, Gallé D, Grésenguet G, 2014. Elimination or control of the onchocerciasis in Africa? Case of Gami village in Central African Republic [in French]. Bull Soc Pathol Exot 107: 188193.
    [Google Scholar]
  6. Mas J et al., 2006. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea. Trop Med Int Health 11: 10821091.
    [Google Scholar]
  7. WHO, 1996. Community Directed Treatment with Ivermectin: Report of a Multi-Country Study. Geneva, Switzerland: World Health Organization, 80.
    [Google Scholar]
  8. Boatin BA, Richards FO Jr., 2006. Control of onchocerciasis. Adv Parasitol 61: 349394.
    [Google Scholar]
  9. Katabarwa M, Habomugisha P, Eyamba A, Agunyo S, Mentou C, 2010. Monitoring ivermectin distributors involved in integrated health care services through community-directed interventions–a comparison of Cameroon and Uganda experiences over a period of three years (2004–2006). Trop Med Int Health 15: 216223.
    [Google Scholar]
  10. Lawrence J, Sodahlon YK, Ogoussan KT, Hopkins AD, 2015. Growth, challenges, and solutions over 25 years of Mectizan and the impact on onchocerciasis control. PLoS Negl Trop Dis 9: e0003507.
    [Google Scholar]
  11. Katabarwa MN, Habomugisha P, Eyamba A, Byamukama E, Nwane P, Arinaitwe A, Musigire J, Tushemereirwe R, Khainza A, 2016. Community-directed interventions are practical and effective in low-resource communities: experience of ivermectin treatment for onchocerciasis control in Cameroon and Uganda, 2004–2010. Int Health 8: 116123.
    [Google Scholar]
  12. Richards FO Jr. et al., 2001. The Carter Center’s assistance to river blindness control programs: establishing treatment objectives and goals for monitoring ivermectin delivery systems on two continents. Am J Trop Med Hyg 65: 108114.
    [Google Scholar]
  13. Katabarwa NM, Mutabazi D, Richards FO Jr., 2000. Controlling onchocerciasis by community-directed, ivermectin-treatment programmes in Uganda: why do some communities succeed and others fail? Ann Trop Med Parasitol 94: 343352.
    [Google Scholar]
  14. Salant P, Dillman DA, 1994. How to Conduct Your Own Survey. New York, NY: John Wiley & Sons.
    [Google Scholar]
  15. Dancey CP, Reidy J, Rowe R, 2012. Statistics for the Health Sciences: A Non-Mathematical Introduction. London, United Kingdom: SAGE.
    [Google Scholar]
  16. Katabarwa MN, Mutabazi D, 1998. The selection and validation of indicators for monitoring progress towards self-sustainment in community-directed, ivermectin-treatment programmes for onchocerciasis control in Uganda. Ann Trop Med Parasitol 92: 859868.
    [Google Scholar]
  17. Katabarwa MN, Richards FO Jr., 2001. Community-directed health (CDH) workers enhance the performance and sustainability of CDH programmes: experience from ivermectin distribution in Uganda. Ann Trop Med Parasitol 95: 275286.
    [Google Scholar]
  18. Baker MC, Krotki K, Sankara DP, Trofimovich L, Zoerhoff KL, Courtney L, Chowdhury D, Linehan M, 2013. Measuring treatment coverage for neglected tropical disease control programs: analysis of a survey design. Am J Epidemiol 178: 268275.
    [Google Scholar]
  19. Guyer B, Atangana S, 1977. A programme of multiple-antigen childhood immunization in Yaounde, Cameroon: first-year evaluation, 1975–1976. Bull World Health Organ 55: 633642.
    [Google Scholar]
  20. Cromwell EA, King JD, McPherson S, Jip FN, Patterson AE, Mosher AW, Evans DS, Emerson PM, 2013. Monitoring of mass distribution interventions for trachoma in Plateau State, Nigeria. PLoS Negl Trop Dis 7: e1995.
    [Google Scholar]
  21. Dierickx S, Gryseels C, Mwesigwa J, O’Neill S, Bannister-Tyrell M, Ronse M, Jaiteh F, Gerrets R, D’Alessandro U, Grietens KP, 2016. Factors associated with non-participation and non-adherence in directly observed mass drug administration for malaria in the Gambia. PLoS One 11: e0148627.
    [Google Scholar]
  22. Jin J, Sklar GE, Min Sen Oh V, Chuen Li S, 2008. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag 4: 269286.
    [Google Scholar]
  23. Whitworth JA, Maude GH, Downham MD, 1996. Clinical and parasitological responses after up to 6.5 years of ivermectin treatment for onchocerciasis. Trop Med Int Health 1: 786793.
    [Google Scholar]
  24. African Programme for Onchocerciasis Control, WHO, 2009. Final Communiqué: Fifteenth Session of the Joint Action Forum, Tunis, Tunisia. Ouagadougou, Burkina Faso: WHO/APOC, 18.
    [Google Scholar]
  25. WHO, 2016. Guidelines for Stopping Mass Drug Administration and Verifying Elimination of Human Onchocerciasis: Criteria and Procedures. Geneva, Switzerland: World Health Organization.
    [Google Scholar]
  26. WHO/APOC, 2012. The WHO African Programme for Onchocerciasis Control: Progress Report 2012. The World Health Organization Year 2012 Progress Report. September 1, 2011–August 31, 2012. Ouagadougou, Burkina Faso: African Programme for Onchocerciasis Control.
    [Google Scholar]
  27. WHO/APOC, 2010. Conceptual and Operational Framework of Onchocerciasis Elimination with Ivermectin Treatment. Ouagadougou, Burkina Faso: WHO/African Programme for Onchocerciaisis Control.
    [Google Scholar]
  28. Burmeister H, Kayembe Kalambayi P, Koulischer G, Oladepo O, Philippon BA, Tarimo E, 2005. Report of the External Evaluation (APOC, WHO). Geneva, Switzerland: World Health Organization. Available at: https://apps.who.int/iris/bitstream/handle/10665/276000/JAF11.10-eng.pdf.
    [Google Scholar]
  29. UN, 2017. World Population Prospects: The 2017 Revision, Key Findings and Advance Tables. New York, NY: Department of Economic and Social Affairs, Population Division.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0680
Loading
/content/journals/10.4269/ajtmh.18-0680
Loading

Data & Media loading...

  • Received : 20 Aug 2018
  • Accepted : 28 Jan 2019
  • Published online : 25 Mar 2019
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error